Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid

被引:83
作者
Karimi, Morvarid
Carl, Juanita L.
Loftin, Susan
Perlmutter, Joel S.
机构
[1] Washington Univ, Dept Neurol, St Louis, MO USA
[2] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO USA
[3] Washington Univ, Program Phys Therapy, St Louis, MO USA
[4] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2006年 / 836卷 / 1-2期
关键词
levodopa; plasma measurements; HPLC; carbidopa; 3-O-methyldopa; dopamine; DOPAC (3,4-dihydroxyphenyl acetic acid);
D O I
10.1016/j.jchromb.2006.03.027
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Plasma measurements of levodopa and its major metabolites including dopamine and 3-O-methyldopa have been limited by cumbersome methods and poor sensitivity within relatively narrow ranges of plasma levels. We now report a modification of an HPLC method that permits concomitant measurements of a wide range of concentrations of levoclopa, dopamine (DA), carbidopa, 3-O-methyldopa (3-OMD) and 3,4-dihydroxyphenyl acetic acid (DOPAC) from one HPLC injection. The recoveries ranged from 77 to 107% with an intra-day precision around 5% (CV) and inter-day CV's about 10-20%. This validated method will simplify pharmacokinetic studies of levodopa and its metabolites for mechanistic studies or therapeutic clinical monitoring which play a crucial role in development of strategies to prolong motor benefits from individual doses and reduce involuntary movements called dykinesias. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:120 / 123
页数:4
相关论文
共 14 条
[1]   SIMPLE AND RAPID MICROMETHOD FOR THE DETERMINATION OF LEVODOPA AND 3-O-METHYLDOPA IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH COULOMETRIC DETECTION [J].
BARUZZI, A ;
CONTIN, M ;
ALBANI, F ;
RIVA, R .
JOURNAL OF CHROMATOGRAPHY, 1986, 375 (01) :165-169
[2]   SIMULTANEOUS DETERMINATION OF L-DOPA AND 3-O-METHYLDOPA IN HUMAN-SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BEERS, MF ;
STERN, M ;
HURTIG, H ;
MELVIN, G ;
SCARPA, A .
JOURNAL OF CHROMATOGRAPHY, 1984, 336 (02) :380-384
[3]   TREATMENT OF IDIOPATHIC PARKINSONISM WITH L-DOPA IN THE ABSENCE AND PRESENCE OF DECARBOXYLASE INHIBITORS - EFFECTS ON PLASMA-LEVELS OF L-DOPA, DOPA DECARBOXYLASE, CATECHOLAMINES AND 3-O-METHYL-DOPA [J].
BOOMSMA, F ;
MEERWALDT, JD ;
INTVELD, AJM ;
HOVESTADT, A ;
SCHALEKAMP, MADH .
JOURNAL OF NEUROLOGY, 1989, 236 (04) :223-230
[4]  
Hornykiewicz O., 1961, WIEN KLIN WOCHENSCHR, V73, P839
[5]  
LIEBERMAN AN, 1970, LANCET, V2, P985
[6]   Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease [J].
Muhlack, S ;
Woitalla, D ;
Welnic, J ;
Twiehaus, S ;
Przuntek, H ;
Müller, T .
NEUROSCIENCE LETTERS, 2004, 363 (03) :284-287
[7]   Synergistic inhibition of respiration in brain mitochondria by nitric oxide and dihydroxyphenylacetic acid (DOPAC) Implications for Parkinson's disease [J].
Nunes, C ;
Almeida, L ;
Laranjinha, J .
NEUROCHEMISTRY INTERNATIONAL, 2005, 47 (03) :173-182
[8]   THE EFFECT OF CARBIDOPA ON THE PHARMACOKINETICS OF INTRAVENOUSLY ADMINISTERED LEVODOPA - THE MECHANISM OF ACTION IN THE TREATMENT OF PARKINSONISM [J].
NUTT, JG ;
WOODWARD, WR ;
ANDERSON, JL .
ANNALS OF NEUROLOGY, 1985, 18 (05) :537-543
[9]   THE ON OFF PHENOMENON IN PARKINSONS-DISEASE - RELATION TO LEVODOPA ABSORPTION AND TRANSPORT [J].
NUTT, JG ;
WOODWARD, WR ;
HAMMERSTAD, JP ;
CARTER, JH ;
ANDERSON, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (08) :483-488
[10]   EFFECT OF PERIPHERAL CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PARKINSONIAN-PATIENTS [J].
NUTT, JG ;
WOODWARD, WR ;
BECKNER, RM ;
STONE, CK ;
BERGGREN, K ;
CARTER, JH ;
GANCHER, ST ;
HAMMERSTAD, JP ;
GORDIN, A .
NEUROLOGY, 1994, 44 (05) :913-919